Gemcitabine and radiation therapy in non-small cell lung cancer: state of the art-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Gemcitabine and radiation therapy in non-small cell lung cancer: state of the art

Published:2006-12 Issue:12 Volume:17 Page:1743-1747
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Mornex F.,Girard N.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/17/12/1743/413608/mdl117.pdf

Reference32 articles.

1. Adjuvant and neoadjuvant treatments for NSCLC;Vokes;Lung Cancer,2002

2. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer;Schiller;N Engl J Med,2002

3. Randomized, multinational, phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for advanced non-small-cell lung cancer: the TAX 326 study group;Fossella;J Clin Oncol,2003

4. Gemcitabine versus the combination of cisplatin and etoposide in patients with inoperable non-small-cell lung cancer in a phase II randomized study;Perng;J Clin Oncol,1997

5. Gemcitabine plus cisplatin vs. gemcitabine plus carboplatin in stage IIIb and IV non-small cell lung cancer: a phase III randomized trial;Zatloukal;Lung Cancer,2003

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Revealing the impact of modified modules flexibility on gemcitabine prodrug nanoassemblies for effective cancer therapy;Journal of Colloid and Interface Science;2025-01

2. Investigation of Lung Cancer Cell Response to Cryoablation and Adjunctive Gemcitabine-Based Cryo-Chemotherapy Using the A549 Cell Line;Biomedicines;2024-06-03

3. RAMP2-AS1 stabilized RAPM2 mRNA through TIA1 to inhibit the progression of non-small cell lung cancer;Cellular and Molecular Biology;2023-12-20

4. X‐Ray Excited Luminescence Materials for Cancer Diagnosis and Theranostics;Laser & Photonics Reviews;2023-11-22

5. Targeting Cell Signaling Pathways in Lung Cancer by Bioactive Phytocompounds;Cancers;2023-08-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3